XOMA (XOMAP) Competitors $25.86 +0.04 (+0.15%) (As of 12/20/2024 05:17 PM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsDividendFinancialsHeadlinesSEC FilingsShort InterestTrends XOMAP vs. ATNFW, SXTPW, DRTSW, WENAW, APLMW, BCTXW, CDIOW, CTCXW, CELUW, and CEROWShould you be buying XOMA stock or one of its competitors? The main competitors of XOMA include 180 Life Sciences (ATNFW), 60 Degrees Pharmaceuticals (SXTPW), Alpha Tau Medical (DRTSW), Anew Medical (WENAW), Apollomics (APLMW), BriaCell Therapeutics (BCTXW), Cardio Diagnostics (CDIOW), Carmell (CTCXW), Celularity (CELUW), and CERo Therapeutics (CEROW). These companies are all part of the "biotechnology" industry. XOMA vs. 180 Life Sciences 60 Degrees Pharmaceuticals Alpha Tau Medical Anew Medical Apollomics BriaCell Therapeutics Cardio Diagnostics Carmell Celularity CERo Therapeutics 180 Life Sciences (NASDAQ:ATNFW) and XOMA (NASDAQ:XOMAP) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, community ranking, valuation, analyst recommendations, media sentiment, risk, profitability, institutional ownership and earnings. Does the media refer more to ATNFW or XOMAP? In the previous week, XOMA had 1 more articles in the media than 180 Life Sciences. MarketBeat recorded 1 mentions for XOMA and 0 mentions for 180 Life Sciences. XOMA's average media sentiment score of 1.00 beat 180 Life Sciences' score of 0.00 indicating that XOMA is being referred to more favorably in the news media. Company Overall Sentiment 180 Life Sciences Neutral XOMA Positive Is ATNFW or XOMAP more profitable? Company Net Margins Return on Equity Return on Assets 180 Life SciencesN/A N/A N/A XOMA N/A N/A N/A Which has better valuation & earnings, ATNFW or XOMAP? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio180 Life SciencesN/AN/AN/AN/AN/AXOMA$9.71MN/AN/AN/AN/A Does the MarketBeat Community prefer ATNFW or XOMAP? 180 Life Sciences and XOMA both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperform180 Life SciencesN/AN/AXOMAN/AN/A SummaryXOMA beats 180 Life Sciences on 3 of the 3 factors compared between the two stocks. Ad Crypto Swap ProfitsURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.>> Register for the Workshop Now Get XOMA News Delivered to You Automatically Sign up to receive the latest news and ratings for XOMAP and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart XOMAP vs. The Competition Export to ExcelMetricXOMABiotechnology IndustryMedical SectorNASDAQ ExchangeMarket CapN/A$166.07M$5.12B$9.07BDividend Yield9.29%3.64%4.91%4.22%P/E RatioN/A114.6691.3417.19Price / SalesN/A17,963.611,117.70116.80Price / CashN/A12.7542.6437.86Price / BookN/A8.404.794.78Net IncomeN/A-$20.67M$120.07M$225.60M7 Day Performance1.57%-1.08%-1.90%-1.23%1 Month Performance0.66%135.79%11.45%3.37%1 Year Performance1.41%136.53%30.63%16.58% XOMA Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)XOMAPXOMAN/A$25.86+0.2%N/A+1.1%$0.00$9.71M0.0013Positive NewsATNFW180 Life SciencesN/A$0.01flatN/A+25.0%$0.00N/A0.007Gap UpSXTPW60 Degrees PharmaceuticalsN/A$0.02-51.3%N/A-48.0%$0.00$502,409.000.002Positive NewsGap DownHigh Trading VolumeDRTSWAlpha Tau MedicalN/A$0.20-21.3%N/A+72.0%$0.00N/A0.0080Positive NewsGap DownWENAWAnew MedicalN/A$0.04-0.3%N/AN/A$0.00N/A0.00N/AGap DownAPLMWApollomicsN/A$0.01+3.1%N/A-50.0%$0.00N/A0.0059News CoverageGap UpBCTXWBriaCell TherapeuticsN/A$0.33-17.1%N/A-81.1%$0.00N/A0.008CDIOWCardio DiagnosticsN/A$0.12+10.2%N/A-27.5%$0.00$35,688.000.007Gap DownHigh Trading VolumeCTCXWCarmellN/A$0.05flatN/AN/A$0.00$32,839.000.009Positive NewsGap DownCELUWCelularityN/A$0.02flatN/A-20.0%$0.00$48.20M0.00220Positive NewsGap UpCEROWCERo TherapeuticsN/A$0.02+25.0%N/AN/A$0.00N/A0.008Gap Down Related Companies and Tools Related Companies 180 Life Sciences Alternatives 60 Degrees Pharmaceuticals Alternatives Alpha Tau Medical Alternatives Anew Medical Alternatives Apollomics Alternatives BriaCell Therapeutics Alternatives Cardio Diagnostics Alternatives Carmell Alternatives Celularity Alternatives CERo Therapeutics Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:XOMAP) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTop Picks for Trump’s Pro-Crypto AmericaCoins Set to Soar with a Pro-Crypto White House President-Elect Donald Trump is reported to be holding over...Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding XOMA Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share XOMA With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free XOMAP Stock Alerts